Pazorene 200mg Film Coated Tablets

Manufacturer
NOVUGEN ONCOLOGY SDN. BHD.(MALAYSIA)

Registraction Number
MAL24116024AZ

Content:
Pazorene 200 mg Film-Coated Tablets contain Pazopanib Hydrochloride 200 mg as the active ingredient. Each tablet is designed for oral use only.
Indications:

• Advanced or metastatic renal cell carcinoma (RCC): Pazorene is used to treat kidney cancer that has spread to other organs.
• Advanced soft tissue sarcoma (STS): Pazorene is used to treat certain types of cancer affecting supportive tissues in the body, such as muscles, blood vessels, and fat tissue.

• Dosage: The recommended dose is 800 mg orally once daily. For patients with moderate hepatic impairment, the dose should be reduced to 200 mg per day.
• Administration: Take the tablet orally with water, swallowing it whole. Do not crush or chew the tablet.
• Timing: Take Pazorene on an empty stomach, either one hour before or two hours after food.
• Precautions: Inform your doctor if you have heart disease, liver disease, blood pressure issues, or any other health conditions. Avoid taking Pazorene with certain medications that may interact with it.
• Storage: Store below 30°C, away from moisture and heat.